KAM
Krensavage Asset Management Portfolio holdings
AUM
$189M
This Quarter Return
+7.4%
1 Year Return
+19.71%
3 Year Return
+56.44%
5 Year Return
+120.01%
10 Year Return
+215.64%
AUM
$265M
AUM Growth
+$265M
(+21%)
Cap. Flow
+$35.9M
Cap. Flow
% of AUM
13.55%
Top 10 Holdings %
Top 10 Hldgs %
72.11%
Holding
24
New
1
Increased
20
Reduced
–
Closed
2
Top Buys
| 1 |
Enanta Pharmaceuticals
ENTA
|
$12.7M |
| 2 |
Orthofix Medical
OFIX
|
$7.08M |
| 3 |
SPPI
Spectrum Pharmaceuticals Inc
SPPI
|
$5.77M |
| 4 |
Avanos Medical
AVNS
|
$5.35M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$3.65M |
Top Sells
| 1 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$18.6M |
| 2 |
AbbVie
ABBV
|
$4.1M |
Sector Composition
| 1 | Healthcare | 72.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Enanta Pharmaceuticals
ENTA
$180M
| $31.8M | 11.99% | 706,908 +282,892 | +67% | +$12.7M |
|
2
United Therapeutics
UTHR
$13.8B
| $25.9M | 9.77% | 148,858 +18,057 | +14% | +$3.14M |
|
|
IPXL
3
DELISTED
Impax Laboratories, Inc.
IPXL
| $20.9M | 7.89% | 455,475 +44,531 | +11% | +$2.04M |
|
|
4
Teva Pharmaceuticals
TEVA
$21.1B
| $18.3M | 6.91% | 309,962 +61,762 | +25% | +$3.65M |
|
|
5
Avanos Medical
AVNS
$554M
| $17.7M | 6.66% | 436,243 +132,093 | +43% | +$5.35M |
|
|
6
Orthofix Medical
OFIX
$592M
| $17.3M | 6.54% | 523,447 +213,749 | +69% | +$7.08M |
|
|
SCMP
7
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $15.9M | 5.99% | 967,404 +33,538 | +4% | +$551K |
|
8
CONMED
CNMD
$1.68B
| $15.5M | 5.83% | 265,428 +14,154 | +6% | +$825K |
|
9
Merck
MRK
$210B
| $12.6M | 4.77% | 222,103 +12,799 | +6% | +$729K |
|
|
SRGA
10
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $11.4M | 4.31% | 1,770,072 +68,614 | +4% | +$443K |
|
|
HRC
11
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $10.8M | 4.08% | 199,113 +10,786 | +6% | +$586K |
|
12
Amgen
AMGN
$155B
| $10.6M | 4% | 69,086 +12,086 | +21% | +$1.86M |
|
13
Assertio
ASRT
$80.4M
| $7.79M | 2.94% | 362,887 +19,341 | +6% | +$415K |
|
|
IVC
14
DELISTED
Invacare Corporation
IVC
| $7.65M | 2.88% | 353,632 +18,870 | +6% | +$408K |
|
|
AGN
15
DELISTED
Allergan plc
AGN
| $7.07M | 2.67% | 23,290 +1,336 | +6% | +$405K |
|
|
SPPI
16
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $5.77M | 2.18% | +843,702 | New | +$5.77M |
|
|
VXRT
17
DELISTED
Vaxart
VXRT
| $3.39M | 1.28% | 1,638,492 +281,840 | +21% | +$583K |
|
18
Innoviva
INVA
$1.29B
| $3.08M | 1.16% | 170,308 +9,120 | +6% | +$165K |
|
|
JNP
19
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
| $3M | 1.13% | 327,617 +11,468 | +4% | +$105K |
|
|
STRR
20
DELISTED
Star Equity Holdings
STRR
| $1.92M | 0.73% | 443,099 +23,495 | +6% | +$102K |
|
|
FURX
21
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
| $1.42M | 0.54% | 145,544 | – | – |
|
|
22
AbbVie
ABBV
$372B
| – | – | -70,000 | Closed | -$4.1M |
|
|
AMAG
23
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| – | – | -341,091 | Closed | -$18.6M |
|